| The influence of illness‐related variables, personal resources and context‐related factors on real‐life functioning of people with schizophrenia S Galderisi, A Rossi, P Rocca, A Bertolino, A Mucci, P Bucci, P Rucci, ... World Psychiatry 13 (3), 275-287, 2014 | 495 | 2014 |
| Suicide during perinatal period: epidemiology, risk factors, and clinical correlates L Orsolini, A Valchera, R Vecchiotti, C Tomasetti, F Iasevoli, M Fornaro, ... Frontiers in psychiatry 7, 138, 2016 | 250 | 2016 |
| Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism A De Bartolomeis, C Tomasetti, F Iasevoli CNS drugs 29 (9), 773-799, 2015 | 207 | 2015 |
| Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a T Serchov, HW Clement, MK Schwarz, F Iasevoli, DK Tosh, M Idzko, ... Neuron 87 (3), 549-562, 2015 | 199 | 2015 |
| Neuropsychiatric disorders in Cushing's syndrome R Pivonello, C Simeoli, MC De Martino, A Cozzolino, M De Leo, ... Frontiers in neuroscience 9, 129, 2015 | 194 | 2015 |
| Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy F Iasevoli, M Fornaro, G D'Urso, D Galletta, C Casella, M Paternoster, ... Psychological medicine 51 (6), 1054-1056, 2021 | 182 | 2021 |
| Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant … F Iasevoli, S Giordano, R Balletta, G Latte, MV Formato, E Prinzivalli, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 34-48, 2016 | 181 | 2016 |
| The relationship between emotional regulation and eating behaviour: a multidimensional analysis of obesity psychopathology F Micanti, F Iasevoli, C Cucciniello, R Costabile, G Loiarro, G Pecoraro, ... Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity 22, 105-115, 2017 | 147 | 2017 |
| An update of safety of clinically used atypical antipsychotics L Orsolini, C Tomasetti, A Valchera, R Vecchiotti, I Matarazzo, F Vellante, ... Expert opinion on drug safety 15 (10), 1329-1347, 2016 | 140 | 2016 |
| Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders … A de Bartolomeis, G Latte, C Tomasetti, F Iasevoli Molecular neurobiology 49, 484-511, 2014 | 136 | 2014 |
| The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice D De Berardis, S Marini, M Fornaro, V Srinivasan, F Iasevoli, C Tomasetti, ... International journal of molecular sciences 14 (6), 12458-12483, 2013 | 117 | 2013 |
| Targeting the noradrenergic system in posttraumatic stress disorder: a systematic review and meta-analysis of prazosin trials DD Berardis, S Marini, N Serroni, F Iasevoli, C Tomasetti, ... Current drug targets 16 (10), 1094-1106, 2015 | 110 | 2015 |
| Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic … A de Bartolomeis, EF Buonaguro, F Iasevoli Psychopharmacology 225, 1-19, 2013 | 107 | 2013 |
| Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to … A de Bartolomeis, R Balletta, S Giordano, EF Buonaguro, G Latte, ... Psychiatry research 210 (2), 387-395, 2013 | 104 | 2013 |
| The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. A de Bartolomeis, F Iasevoli Psychopharmacology bulletin 37 (3), 51-83, 2003 | 103 | 2003 |
| Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression D De Berardis, M Fornaro, N Serroni, D Campanella, G Rapini, L Olivieri, ... International journal of molecular sciences 16 (1), 1111-1130, 2015 | 97 | 2015 |
| A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects S Tosato, U Albert, S Tomassi, F Iasevoli, C Carmassi, S Ferrari, ... The Journal of clinical psychiatry 78 (5), 1643, 2017 | 94 | 2017 |
| Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases F Iasevoli, C Tomasetti, A de Bartolomeis Neurochemical research 38, 1-22, 2013 | 94 | 2013 |
| Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia A De Bartolomeis, C Sarappa, S Magara, F Iasevoli European journal of pharmacology 682 (1-3), 1-11, 2012 | 88 | 2012 |
| The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview G Martinotti, M Lupi, F Sarchione, R Santacroce, A Salone, D De Berardis, ... Current pharmaceutical design 19 (35), 6367-6374, 2013 | 86 | 2013 |
